Company: XOMAP
Filing Date: 2025-10-03
Form Type: 424B5
Source: 0001193125-25-230393
Chunk: 17

Company: XOMA Royalty Corp
Filing Date: 2025-10-03
Form: 424B5
Chunk 17
---
 subject to adjustment, the holders will receive a maximum of 1.25313 shares of our Common Stock per depositary share, which may result in a holder

S-12

receiving value that is less than the liquidation preference of the depositary shares. In addition, those features of the Series B Preferred Stock and depositary shares may have the effect of inhibiting a third party from making an acquisition proposal for our Company or of delaying, deferring or preventing a change of control of our Company under circumstances that otherwise could provide the holders of our Common Stock and depositary shares representing interests in the Series B Preferred Stock with the opportunity to realize a premium over the then-current market price or that stockholders may otherwise believe is in their best interests. The market price of the depositary shares could be substantially affected by various factors. The market price of the depositary shares will depend on many factors, which may change from time to time, including, without limitation:

| • |     | prevailing interest rates, increases in which may have an adverse effect on the market price of the depositary 
 shares;                                                                                                        |

| • |     | the annual yield from distributions on the depositary shares as compared to yields on other financial 
 instruments;                                                                                          |

| • |     | actual or anticipated variations in our operating results from quarter to quarter; |

| • |     | actual or anticipated variations in our operating results from the expectations of securities analysts and 
 investors;                                                                                                 |

| • |     | actual or anticipated variations in our operating results from those of our competitors; |

| • |     | sales of equity or other securities by us or our stockholders in the future; |

| • |     | changes in expectations as to our future financial performance, including financial estimates by securities 
 analysts and investors;                                                                                     |

| • |     | departures of key executives or directors; |

| • |     | resignation of our auditors; |

| • |     | announcements by us or our competitors of significant contracts, acquisitions, strategic partnerships, financing 
 efforts or capital commitments;                                                                                  |

| • |     | involvement in litigation or governmental investigations or enforcement activity; |

| • |     | stock price and volume fluctuations attributable to inconsistent trading volume levels of our shares; |

| • |     | general economic and stock market conditions; |

| • |     | regulatory or political developments; |

| • |     | changes in trade policies, including tariffs or other trade restrictions or the threat of such actions; |

| • |